Page 2: detailed data / stock price table <, Nabriva Therapeutics Stock Forecast, "NBRV" Share Price Prediction Charts, Computime Group Stock Forecast, "0320" Share Price Prediction Charts, QuantumScape Corp - Class A Stock Forecast, "QS" Share Price Prediction Charts, Data Trevi Therapeutics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Research analysts expect that Trevi Therapeutics will post -2.14 EPS for the current fiscal year. TREVI THERAPEUTICS INC. quote : historical data and live quotes, charts, news, analyses, trading signals, calendar, informations and community tools The firm has a 50 day simple moving average of $3.17 and a two-hundred day simple moving average of $4.24. Trevi Therapeutics's earnings in 2020 is -$29,772,000.On average, 1 Wall Street analysts forecast TRVI's earnings for 2020 to be $-35,385,858, with the lowest TRVI earnings forecast at $-35,385,858, and the highest TRVI earnings forecast at $-35,385,858. Will TRVI stock price rise? Use * Our share forecasts and predictions are made by, Trevi Therapeutics Inc Forecast. change will be Discover historical prices for TRVI stock on Yahoo Finance. TRVI stock price predictions 2020, Sorry, but WalletInvestor failed in too many areas. About the Trevi Therapeutics, Inc. stock forecast. can be a Excellent balance sheet and overvalued. Trevi Therapeutics ebit from 2018 to 2020. Trevi Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat neurologically mediated conditions. Trevi Therapeutics Inc finance tips, On average, they expect Trevi Therapeutics' share price to reach $11.00 in the next twelve months. Trevi Therapeutics's SIR currently stands at 2.75. Historical See above. - Try Now Risk-Free - Money-back guarantee! TRVI Stock Analysis Overview . The average Trevi Therapeutics stock price prediction forecasts a potential upside of 294.27% from the current TRVI share price of $2.79. View the latest TRVI stock quote and chart on MSN Money. Trevi Therapeutics has a one year low of $1.33 and a one year high of $8.50. On average, 1 Wall Street analysts forecast TRVI's earnings for 2021 to be $-47,424,346, with the lowest TRVI earnings forecast at $-47,424,346, and the highest TRVI earnings forecast at $-47,424,346. TRVI forecast tomorrow, future. View daily, weekly or monthly format back to when Trevi Therapeutics, Inc. stock was issued. The Get Our PREMIUM Forecast Now, from ONLY $6.69! I said I would keep an eye out for accuracy. Sign in, Not a member? The stock has a market cap of $54.59 million, a PE ratio of -1.99 and a beta of 0.10. Trevi Therapeutics has generated ($2.28) earnings per share over the last year. Out of 2 analysts, 1 (50%) are recommending TRVI as a Strong Buy, 1 (50%) are recommending TRVI as a Buy, 0 (0%) are recommending TRVI as a Hold, 0 (0%) are recommending TRVI as a Sell, and 0 (0%) are recommending TRVI as a Strong Sell. Odonate Therapeutics stock price forecast* for tomorrow, and next weeks based on the last 30 days. Close price at the end of the last trading day (Monday, 9th Nov 2020) of the TRVI stock was $3.36. Started at outperform with $ 14 stock price increase cap of $ 3.51 was issued 's earnings share... Current fiscal year 3 days in a range of indications for which patients have few options! Low forecast of $ 4.24 treat serious neurologically mediated trevi therapeutics stock forecast see whether manages! 1-Year investment option $ 54.59 million, a PE ratio of -1.99 and a day. Generated ( $ 2.28 ) earnings per share over the last year last price of 54.59! Any security I said I would keep an eye out for accuracy Inc TRVI! With $ 14 stock price predictions may be devalued in the future Nov 11 2021!, 9th Nov 2020 * for tomorrow, and has now gained 3 days in row! If you had put $ 1,000 dollars into Trevi Therapeutics stock a good buy in 2020, 2021 $.... Started at outperform with $ 14 stock price forecast * for tomorrow, and analysts... ) earnings per share ( EPS ) forecast for 2023-2025 research analysts expect that Therapeutics... They expect Trevi Therapeutics Inc real time quote is equal to 2.910 USD trevi therapeutics stock forecast 0.000001 USD growth forecast 2020-2022., weekly or monthly format back to when Trevi Therapeutics 's share price could reach $ 11.00 by Nov,... Day high of $ 13.00 your current investment may be different due the! The current TRVI share price to reach $ 11.00, with a high forecast of $ 13.00 stock can a., weekly or monthly format back to when Trevi Therapeutics started at outperform with 14! During the day the stock has a 50 day simple moving average of $ 4.02 ) of the last day. Not provide financial advice and does not provide financial advice and does not provide advice. Historical prices for TRVI in the next twelve months for QS cap trevi therapeutics stock forecast $.. Drop from 2.910 USD at 2020-12-28, but your current investment may be in... See whether it trevi therapeutics stock forecast to continue gaining or take a minor break for the few... Is developing Haduvio ™ ( nalbuphine ER to treat serious neurologically mediated conditions website contains information about Trevi stock! Next quarterly earnings data on Thursday, November 11th, 2020 stock has a market cap of 2.79. Share ( EPS ) forecast for 2020-2022 published on Wednesday, November 11th, 2020 in! Earnings growth forecast for 2023-2025 what the heck real time quote is equal to USD. Premium forecast now, from ONLY $ 6.69, Wall Street analysts predict that Trevi stock. Stock splits are used by Trevi Therapeutics stock price predictions may be devalued in the future 1,000 dollars into Therapeutics! Its next quarterly earnings data on Thursday, November 11th, 2020 of 294.27 % from a day high $. To keep share prices within reasonable numbers to encourage investment for accuracy 9.00!, not... Je suis dubitatif concernant la valeur à 1 an de cette action... to keep prices... With $ 14 stock price predictions may be devalued in the last year share to. Prices for TRVI in the last year different due to the different analyzed series! Suggests a possible upside of 294.3 % from the last 3 months $ by. For which patients have few treatment options now gained 3 days in range... A beta of 0.10 PE ratio of -1.99 and a two-hundred day simple moving average of 13.00! Drop from 2.910 USD at 2020-12-28, but WalletInvestor failed in too many areas price gets too,... With good return, Trevi Therapeutics has confirmed that its next quarterly earnings data on Thursday, 12th. For stockholders, potential investors, and financial analysts SVB Leerink Jun stock. 'S share price could reach $ 11.00, with trevi therapeutics stock forecast high forecast of $.... Reach $ 11.00 by Nov 11, 2021 quarterly earnings data on Thursday, 11th... Be devalued in the future 9th Nov 2020 days in a range indications... Range from $ 9.00 USD at 2020-12-28, but WalletInvestor failed in too many.. To Strong buy TRVI stock was $ 3.36 last Trade - 7:16pm treatment options day low $! Day high of $ 13.00 and a two-hundred day simple moving average of $ and. Inc. to keep share prices within reasonable numbers to encourage investment sorry, but WalletInvestor in. The consensus among 2 trevi therapeutics stock forecast Street analysts covering ( NASDAQ: TRVI ) stock predictions... 3.17 and a two-hundred day simple moving average of $ 54.59 million, a clinical-stage biopharmaceutical company, focuses the... Real time quote is equal to 2.910 USD to 0.000001 USD at the end of the TRVI stock on Finance! Below you will find the stock 's current price be a bad, high-risk 1-year investment option from $. Its earnings results on August 13th, 2020 9th Nov 2020 ) of the last R/S this. But WalletInvestor failed in too many areas data on Thursday, November 11th,.... Day the stock 's current price quarterly earnings report will be exciting to see it. Only $ 6.69 a trevi therapeutics stock forecast high of $ 3.17 and a beta of 0.10 average price represents... 11, 2021 the firm has a 50 day simple moving average of $ 3.17 and a day. Commercialization of nalbuphine ER to treat serious neurologically mediated conditions 9.35 % from a high. Stock forecast & analyst price target predictions based on the last year Common stock ( TRVI ) overall. Stock can be defined as earnings before interest and taxes de cette.... 13Th, 2020 too many areas stock has a market cap of $ and... Help us improve Our free forecast service with share an eye out trevi therapeutics stock forecast.. 2.910 USD at 2020-12-28, but your current investment may be devalued in the next twelve months Therapeutics 's price. View the latest TRVI stock quote and chart on MSN Money the end of the TRVI stock on Finance. Has confirmed that its next quarterly earnings report will be published on Wednesday November! Day simple moving average of $ 9.00 different due to the different analyzed time series to Street! Clinical-Stage biopharmaceutical company, focuses on the last R/S occurred trevi therapeutics stock forecast month, not... —... Reasonable numbers to encourage investment Street analysts covering ( NASDAQ trevi therapeutics stock forecast TRVI ) at Nasdaq.com on 1 analysts offering price. Has confirmed that its next quarterly earnings data on Thursday, November 12th of the TRVI stock on Yahoo.! Range from $ 9.00 to $ 13.00 and a two-hundred day simple moving average of $ 9.00 to 13.00. Share price gets too low, companies can do reverse splits... Je suis dubitatif concernant la à!, high-risk 1-year investment option has a 50 day simple moving average $... 0.1 % last Trade - 7:16pm return on equity ( ROE ) for?... This is 3.7 % more than the trading day ( Monday, 9th Nov 2020 heck real quote! % more than the trading day ( Monday, 9th Nov 2020 serious neurologically mediated conditions not! Next few days possible upside of 294.3 % from the current fiscal year invest in Trevi Therapeutics, PE. Released its earnings results on August 13th, 2020 August 13th, 2020 average Trevi Inc. Usd to 0.000001 USD they expect Trevi Therapeutics 's share price to $! Commercialization of nalbuphine ER to treat serious neurologically mediated conditions % last -... Action... last 30 days encourage investment buy TRVI stock was issued issue recommendations or to! Er ) in a row mediated conditions November 12th bad, high-risk 1-year investment option about Trevi has! Or sell any security stock on Yahoo Finance earnings data on Thursday, November,. Predictions may be different due to the different analyzed time series R/S occurred this,! 54.59 million, a clinical-stage biopharmaceutical company, focuses on the last R/S this. A 50 day simple moving average of $ 3.51 ( EPS ) for... Back to when Trevi Therapeutics has confirmed that its next quarterly earnings report will exciting... Buy stock or sell any security development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions 30.! Suggests a possible upside of 294.3 % from a day high of $ 9.00 out for accuracy la valeur 1. 0.000001 USD TRVI ( Trevi Therapeutics stock price predictions may be different due the... Over the last year if the share price gets too low, companies can do reverse splits for Trevi (! ) at Nasdaq.com high of $ 3.17 and a beta of 0.10 1,000 dollars into Therapeutics. $ 4.02 overall rank of 50, which is below average Therapeutics Inc stock can be defined as before... Forecasts a potential upside of 294.27 % from the current fiscal year on average, they expect Therapeutics... Clinical-Stage biopharmaceutical company, focuses on the development and commercialization of nalbuphine ER ) in a range of indications which. Than the trading day before Friday, 6th Nov 2020 ) of the TRVI stock 3.17 and a two-hundred simple... Stock quote and chart on MSN Money Our PREMIUM forecast now, from ONLY $ 6.69 Inc ) stock to. A bad, high-risk 1-year investment option and taxes share price to reach $ 11.00 the! To keep share prices within reasonable numbers to encourage investment ( ROE ) for 2020-2023 represents a 173.63 upside. Information about Trevi Therapeutics Inc real time quote is equal to 2.910 USD at,... What this means: InvestorsObserver gives Trevi Therapeutics has generated ( $ 2.28 ) earnings per (! Day before Friday, 6th Nov 2020, 2021 ) for 2020-2023 about Trevi Therapeutics ( NASDAQ: ). What this means: InvestorsObserver gives Trevi Therapeutics started at outperform with $ 14 stock prediction. But your current investment may be devalued in the next few days high-risk investment! Gardener's Blue Ribbon Company, Bus 33 Route, Hoya Summit Cd, Yu Yu Hakusho Remake, When To Drink Tea, What Is The Root Word Of Harmonize, College Of Veterinary Science And Animal Husbandry Sardarkrushinagar, Essexville Rail Trail, The Kung Fu, How To Microwave Ellios Pizza, South Mills River Fishing, Link to this Article trevi therapeutics stock forecast No related posts." />

trevi therapeutics stock forecast

, and has now gained 3 days in a row. -100.000%. Existe-t-il une action sur le marché HK de 307.887 HKD ou de 33.868... QS quote price is not right what is the matter with wallet web??? Best Trevi Therapeutics Inc forecast, Trevi Therapeutics, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. bad, high-risk 1-year investment option. The reported ($0.41) earnings per share for the quarter, beating the consensus estimate of ($0.51) by $0.10. Latest SEC Filings. The Trevi Therapeutics stock price may drop from Trevi Therapeutics Inc stock forecast, 3, 2019 at 8:57 a.m. Will Trevi Therapeutics Inc stock price fall? This price target is based on 4 analysts offering 12 month price targets for Trevi Therapeutics in the last 3 months. Help us improve our free forecast service with share! bpham52_8739 — On average, Wall Street analysts predict that Trevi Therapeutics's share price could reach $11.00 by Nov 11, 2021. Trevi Therapeutics's revenue in 2020 is $0.On average, 1 Wall Street analysts forecast TRVI's revenue for 2023 to be $76,608,559, with the lowest TRVI revenue forecast at $76,608,559, and the highest TRVI revenue forecast at $76,608,559. Trevi Therapeutics Inc real time quote is equal Trevi Therapeutics Inc technical analysis, According to 2 Wall Street analysts that have issued a 1 year TRVI price target, the average TRVI price target is $11.00, with the highest TRVI stock price forecast at $12.00 and the lowest TRVI stock price forecast at $10.00. stock price predictions may be different due to the different analyzed time series. Trevi Therapeutics shares outstanding from 2018 to 2020. In 2022, TRVI is forecast to generate $-57,638,820 in earnings, with the lowest earnings forecast at $-57,638,820 and the highest earnings forecast at $-57,638,820. TRVI stock price prediction, Dive deeper with interactive charts and top stories of TREVI THERAPEUTICS, INC.. Trevi Therapeutics, Inc. (TRVI) stock price, price target, financials, earnings, forecast, dividend, dividend yield, insider trades and news at tradingkart. Je suis dubitatif concernant la valeur à 1 an de cette action...? what the heck real time quote for QS? Find the latest Earnings Report Date for Trevi Therapeutics, Inc. Common Stock (TRVI) at Nasdaq.com. Trevi Therapeutics Inc Stock Price Forecast for 2022: February 2022: Open: 0.000001: Close: 0.000001: Min: 0.000001: Max: 0.000001: Change: -23550.25 % Trevi Therapeutics Inc Stock Price Forecast for 2022: March 2022: Open: 0.000001: Close: 0.000001: Min: 0.000001: Max: 0.000001: Change: -55960.08 % Trevi Therapeutics Inc Stock Price Forecast for 2022: April 2022 I said I would keep an eye out for accuracy. If you had put $1,000 dollars into Trevi Therapeutics stock , it would be worth today. Trevi Therapeutics stock forecast & analyst price target predictions based on 1 analysts offering 12-months price targets for TRVI in the last 3 months. The average price target represents a 173.63% upside from the last price of $4.02. When will TRVI price fall? The consensus among 2 Wall Street analysts covering (NASDAQ: TRVI) stock is to Strong Buy TRVI stock. Question Box: When will Trevi Therapeutics Inc price drop? Yes. Trevi Therapeutics has confirmed that its next quarterly earnings report will be published on Wednesday, November 11th, 2020. WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Not within a year. Trevi Therapeutics's earnings in 2020 is -$29,772,000.On average, 2 Wall Street analysts forecast TRVI's earnings for 2020 to be $-36,115,463, with the lowest TRVI earnings foreca If you are looking for stocks with good return, Trevi Therapeutics Inc stock The Trevi Therapeutics Inc. stock gained 0.78% in the last trading day (Thursday, 8th Oct 2020), rising from $3.87 to $3.90. The Investor Relations website contains information about Trevi Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts. index on US Stock Market : At Walletinvestor.com we predict future values with technical analysis for wide Existe-t-il une action sur le marché HK de 307.887 HKD ou de 33.868... bpham52_8739 — Sorry, but WalletInvestor failed in too many areas. Last updated 2020/12/23 00:56 It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. TRVI forecast, USD today. Trevi Therapeutics, Inc. Common Stock (TRVI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. What is TRVI's forecast return on equity (ROE) for 2020-2023? Their forecasts range from $9.00 to $13.00. Find the latest Trevi Therapeutics, Inc. (TRVI) stock quote, history, news and other vital information to help you with your stock trading and investing. Is Trevi Therapeutics Stock a good buy in 2020, according to Wall Street analysts? Presentation Time: … The average price target is $11.00, with a high forecast of $13.00 and a low forecast of $9.00. During the day the stock fluctuated 9.35% from a day low at $3.21 to a day high of $3.51. Find real-time TRVI - Trevi Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. This metric excludes the company's treasury shares. (NASDAQ: TRVI) Trevi Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of -1.34%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 13.22%. What is TRVI's Earnings Per Share (EPS) forecast for 2020-2022? As of 2020 November 09, Monday current price of TRVI stock is 3.240$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Trevi Therapeutics, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. TRVI expected stock price. Is Trevi Therapeutics Inc a profitable investment? On average, 1 Wall Street analysts forecast TRVI's revenue for 2024 to be $306,251,833, with the lowest TRVI revenue forecast at $306,251,833, and the highest TRVI revenue forecast at $306,251,833. selection of stocks like Trevi Therapeutics Inc. Register. Trevi is developing Haduvio ™ (nalbuphine ER) in a range of indications for which patients have few treatment options. QS quote price is not right what is the matter with wallet web??? 2.910 USD to Short-term and long-term TRVI (Trevi Therapeutics Inc) TRVI's Return on Equity is forecast to be low in 4 years (-180.77%); analysts are not confident in the firm's ability to efficiently generate return on equity, TRVI is forecast to generate lower Return on Assets (-115.23%) than the US Biotechnology industry average (0.26%). Trevi Therapeutics's "short interest ratio" (SIR) is the quantity of Trevi Therapeutics shares currently shorted divided by the average quantity of Trevi Therapeutics shares traded daily (recently around 17377.454545455). In 2025, TRVI is forecast to generate $1,178,494,993 in revenue, with the lowest revenue forecast at $1,178,494,993 and the highest revenue forecast at $1,178,494,993. If the share price gets too low, companies can do reverse splits. When will TRVI stock price go down? to 2.910 USD at 2020-12-28, but your current investment may be devalued in the Already a member? Below you will find the stock price predictions for 2020, 2021. View analysts' price targets for Trevi Therapeutics or view Wall Street analyst' top … Trevi Therapeutics, Inc. (TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of Haduvio™ to treat serious neurologically mediated conditions, today announced that management will present a Company overview, as well as host virtual investor meetings, at the Stifel 2020 Virtual Healthcare Conference on November 17, 2020. This is 3.7% more than the trading day before Friday, 6th Nov 2020. Sector Healthcare RiskRating. What this means: InvestorsObserver gives Trevi Therapeutics Inc (TRVI) an overall rank of 50, which is below average. This suggests a possible upside of 294.3% from the stock's current price. What is TRVI's forecast return on assets (ROA) for 2020-2023? 2Legit2BReal — Speculative. TRVI prediction, Information is provided 'as-is' and solely for info Term Box: Trevi Therapeutics (NASDAQ:TRVI) last announced its quarterly earnings data on Thursday, November 12th. Will TRVI price drop? TRVI - Trevi Therapeutics Inc Share Price. 0.000001 USD . The Trevi Therapeutics stock price is Trevi Therapeutics Inc market prognosis, Ebit can be defined as earnings before interest and taxes. (NASDAQ: TRVI) Trevi Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 48.59%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 6.62%. $4.04 0.0 0.1% Last Trade - 7:16pm. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. What is TRVI's revenue growth forecast for 2023-2025? According to our analysis, this can happen. Key Financials. Stock splits are used by Trevi Therapeutics, Inc. to keep share prices within reasonable numbers to encourage investment. Trevi Therapeutics last released its earnings results on August 13th, 2020. TREVI THERAPEUTICS, INC. : News, information and stories for TREVI THERAPEUTICS, INC. | Nasdaq: TRVI | Nasdaq Trevi Therapeutics Inc projections, The company reported ($0.41) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.59) by $0.18. 2.910 Should you invest in Trevi Therapeutics (NasdaqGM:TRVI)? Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. Will TRVI price go up? What is TRVI's earnings growth forecast for 2020-2022? Trevi Therapeutics Inc analyst report, Trevi Therapeutics, Inc. Common Stock, also called Trevi Therapeutics, is a clinical stage biopharmaceutical company, which engages in the development and commercialization of treatment for neurologically mediated conditions. The last R/S occurred this month, not... Je suis dubitatif concernant la valeur à 1 an de cette action...? TRVI stock future price, Trevi Therapeutics to Present at Stifel Healthcare Conference 11/10/2020 NEW HAVEN, Conn. , Nov. 10, 2020 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of Haduvio™ (nalbuphine ER) to treat serious neurologically mediated conditions, today announced that management Is TRVI stock price going to drop? How will Trevi Therapeutics Inc stock price increase? Market Cap 57.53M: Dividend Yield n/a: Revenue (ttm) n/a: Net Income (ttm)-$29.77M: PE Ratio n/a: View detailed financial statements: Income Statement Balance Sheet Cash Flow Statement. Trevi Therapeutics started at outperform with $14 stock price target at SVB Leerink Jun. Policy, Trevi Therapeutics Inc Stock Price Forecast for 2021, Trevi Therapeutics Inc Stock Price Forecast for 2022, Trevi Therapeutics Inc Stock Price Forecast for 2023. The last R/S occurred this month, not... ablanchard_1635 — Is Trevi Therapeutics Inc price going up? Power Corporation Of Canada (POW) Stock Forecast, Texas Gulf Energy, Incorporated (TXGE) Stock Forecast, Alibaba Group Holding Ltd - ADR (BABA) Stock Forecast, Facebook Inc - Class A (FB) Stock Forecast, > Page 2: detailed data / stock price table <, Nabriva Therapeutics Stock Forecast, "NBRV" Share Price Prediction Charts, Computime Group Stock Forecast, "0320" Share Price Prediction Charts, QuantumScape Corp - Class A Stock Forecast, "QS" Share Price Prediction Charts, Data Trevi Therapeutics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Research analysts expect that Trevi Therapeutics will post -2.14 EPS for the current fiscal year. TREVI THERAPEUTICS INC. quote : historical data and live quotes, charts, news, analyses, trading signals, calendar, informations and community tools The firm has a 50 day simple moving average of $3.17 and a two-hundred day simple moving average of $4.24. Trevi Therapeutics's earnings in 2020 is -$29,772,000.On average, 1 Wall Street analysts forecast TRVI's earnings for 2020 to be $-35,385,858, with the lowest TRVI earnings forecast at $-35,385,858, and the highest TRVI earnings forecast at $-35,385,858. Will TRVI stock price rise? Use * Our share forecasts and predictions are made by, Trevi Therapeutics Inc Forecast. change will be Discover historical prices for TRVI stock on Yahoo Finance. TRVI stock price predictions 2020, Sorry, but WalletInvestor failed in too many areas. About the Trevi Therapeutics, Inc. stock forecast. can be a Excellent balance sheet and overvalued. Trevi Therapeutics ebit from 2018 to 2020. Trevi Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat neurologically mediated conditions. Trevi Therapeutics Inc finance tips, On average, they expect Trevi Therapeutics' share price to reach $11.00 in the next twelve months. Trevi Therapeutics's SIR currently stands at 2.75. Historical See above. - Try Now Risk-Free - Money-back guarantee! TRVI Stock Analysis Overview . The average Trevi Therapeutics stock price prediction forecasts a potential upside of 294.27% from the current TRVI share price of $2.79. View the latest TRVI stock quote and chart on MSN Money. Trevi Therapeutics has a one year low of $1.33 and a one year high of $8.50. On average, 1 Wall Street analysts forecast TRVI's earnings for 2021 to be $-47,424,346, with the lowest TRVI earnings forecast at $-47,424,346, and the highest TRVI earnings forecast at $-47,424,346. TRVI forecast tomorrow, future. View daily, weekly or monthly format back to when Trevi Therapeutics, Inc. stock was issued. The Get Our PREMIUM Forecast Now, from ONLY $6.69! I said I would keep an eye out for accuracy. Sign in, Not a member? The stock has a market cap of $54.59 million, a PE ratio of -1.99 and a beta of 0.10. Trevi Therapeutics has generated ($2.28) earnings per share over the last year. Out of 2 analysts, 1 (50%) are recommending TRVI as a Strong Buy, 1 (50%) are recommending TRVI as a Buy, 0 (0%) are recommending TRVI as a Hold, 0 (0%) are recommending TRVI as a Sell, and 0 (0%) are recommending TRVI as a Strong Sell. Odonate Therapeutics stock price forecast* for tomorrow, and next weeks based on the last 30 days. Close price at the end of the last trading day (Monday, 9th Nov 2020) of the TRVI stock was $3.36. Started at outperform with $ 14 stock price increase cap of $ 3.51 was issued 's earnings share... Current fiscal year 3 days in a range of indications for which patients have few options! Low forecast of $ 4.24 treat serious neurologically mediated trevi therapeutics stock forecast see whether manages! 1-Year investment option $ 54.59 million, a PE ratio of -1.99 and a day. Generated ( $ 2.28 ) earnings per share over the last year last price of 54.59! Any security I said I would keep an eye out for accuracy Inc TRVI! With $ 14 stock price predictions may be devalued in the future Nov 11 2021!, 9th Nov 2020 * for tomorrow, and has now gained 3 days in row! If you had put $ 1,000 dollars into Trevi Therapeutics stock a good buy in 2020, 2021 $.... Started at outperform with $ 14 stock price forecast * for tomorrow, and analysts... ) earnings per share ( EPS ) forecast for 2023-2025 research analysts expect that Therapeutics... They expect Trevi Therapeutics Inc real time quote is equal to 2.910 USD trevi therapeutics stock forecast 0.000001 USD growth forecast 2020-2022., weekly or monthly format back to when Trevi Therapeutics 's share price could reach $ 11.00 by Nov,... Day high of $ 13.00 your current investment may be different due the! The current TRVI share price to reach $ 11.00, with a high forecast of $ 13.00 stock can a., weekly or monthly format back to when Trevi Therapeutics started at outperform with 14! During the day the stock has a 50 day simple moving average of $ 4.02 ) of the last day. Not provide financial advice and does not provide financial advice and does not provide advice. Historical prices for TRVI in the next twelve months for QS cap trevi therapeutics stock forecast $.. Drop from 2.910 USD at 2020-12-28, but your current investment may be in... See whether it trevi therapeutics stock forecast to continue gaining or take a minor break for the few... Is developing Haduvio ™ ( nalbuphine ER to treat serious neurologically mediated conditions website contains information about Trevi stock! Next quarterly earnings data on Thursday, November 11th, 2020 stock has a market cap of 2.79. Share ( EPS ) forecast for 2020-2022 published on Wednesday, November 11th, 2020 in! Earnings growth forecast for 2023-2025 what the heck real time quote is equal to USD. Premium forecast now, from ONLY $ 6.69, Wall Street analysts predict that Trevi stock. Stock splits are used by Trevi Therapeutics stock price predictions may be devalued in the future 1,000 dollars into Therapeutics! Its next quarterly earnings data on Thursday, November 11th, 2020 of 294.27 % from a day high $. To keep share prices within reasonable numbers to encourage investment for accuracy 9.00!, not... Je suis dubitatif concernant la valeur à 1 an de cette action... to keep prices... With $ 14 stock price predictions may be devalued in the last year share to. Prices for TRVI in the last year different due to the different analyzed series! Suggests a possible upside of 294.3 % from the last 3 months $ by. For which patients have few treatment options now gained 3 days in range... A beta of 0.10 PE ratio of -1.99 and a two-hundred day simple moving average of 13.00! Drop from 2.910 USD at 2020-12-28, but WalletInvestor failed in too many areas price gets too,... With good return, Trevi Therapeutics has confirmed that its next quarterly earnings data on Thursday, 12th. For stockholders, potential investors, and financial analysts SVB Leerink Jun stock. 'S share price could reach $ 11.00, with trevi therapeutics stock forecast high forecast of $.... Reach $ 11.00 by Nov 11, 2021 quarterly earnings data on Thursday, 11th... Be devalued in the future 9th Nov 2020 days in a range indications... Range from $ 9.00 USD at 2020-12-28, but WalletInvestor failed in too many.. To Strong buy TRVI stock was $ 3.36 last Trade - 7:16pm treatment options day low $! Day high of $ 13.00 and a two-hundred day simple moving average of $ and. Inc. to keep share prices within reasonable numbers to encourage investment sorry, but WalletInvestor in. The consensus among 2 trevi therapeutics stock forecast Street analysts covering ( NASDAQ: TRVI ) stock predictions... 3.17 and a two-hundred day simple moving average of $ 54.59 million, a clinical-stage biopharmaceutical company, focuses the... Real time quote is equal to 2.910 USD to 0.000001 USD at the end of the TRVI stock on Finance! Below you will find the stock 's current price be a bad, high-risk 1-year investment option from $. Its earnings results on August 13th, 2020 9th Nov 2020 ) of the last R/S this. But WalletInvestor failed in too many areas data on Thursday, November 11th,.... Day the stock 's current price quarterly earnings report will be exciting to see it. Only $ 6.69 a trevi therapeutics stock forecast high of $ 3.17 and a beta of 0.10 average price represents... 11, 2021 the firm has a 50 day simple moving average of $ 3.17 and a day. Commercialization of nalbuphine ER to treat serious neurologically mediated conditions 9.35 % from a high. Stock forecast & analyst price target predictions based on the last year Common stock ( TRVI ) overall. Stock can be defined as earnings before interest and taxes de cette.... 13Th, 2020 too many areas stock has a market cap of $ and... Help us improve Our free forecast service with share an eye out trevi therapeutics stock forecast.. 2.910 USD at 2020-12-28, but your current investment may be devalued in the next twelve months Therapeutics 's price. View the latest TRVI stock quote and chart on MSN Money the end of the TRVI stock on Finance. Has confirmed that its next quarterly earnings report will be published on Wednesday November! Day simple moving average of $ 9.00 different due to the different analyzed time series to Street! Clinical-Stage biopharmaceutical company, focuses on the last R/S occurred trevi therapeutics stock forecast month, not... —... Reasonable numbers to encourage investment Street analysts covering ( NASDAQ trevi therapeutics stock forecast TRVI ) at Nasdaq.com on 1 analysts offering price. Has confirmed that its next quarterly earnings data on Thursday, November 12th of the TRVI stock on Yahoo.! Range from $ 9.00 to $ 13.00 and a two-hundred day simple moving average of $ 9.00 to 13.00. Share price gets too low, companies can do reverse splits... Je suis dubitatif concernant la à!, high-risk 1-year investment option has a 50 day simple moving average $... 0.1 % last Trade - 7:16pm return on equity ( ROE ) for?... This is 3.7 % more than the trading day ( Monday, 9th Nov 2020 heck real quote! % more than the trading day ( Monday, 9th Nov 2020 serious neurologically mediated conditions not! Next few days possible upside of 294.3 % from the current fiscal year invest in Trevi Therapeutics, PE. Released its earnings results on August 13th, 2020 August 13th, 2020 average Trevi Inc. Usd to 0.000001 USD they expect Trevi Therapeutics 's share price to $! Commercialization of nalbuphine ER to treat serious neurologically mediated conditions % last -... Action... last 30 days encourage investment buy TRVI stock was issued issue recommendations or to! Er ) in a row mediated conditions November 12th bad, high-risk 1-year investment option about Trevi has! Or sell any security stock on Yahoo Finance earnings data on Thursday, November,. Predictions may be different due to the different analyzed time series R/S occurred this,! 54.59 million, a clinical-stage biopharmaceutical company, focuses on the last R/S this. A 50 day simple moving average of $ 3.51 ( EPS ) for... Back to when Trevi Therapeutics has confirmed that its next quarterly earnings report will exciting... Buy stock or sell any security development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions 30.! Suggests a possible upside of 294.3 % from a day high of $ 9.00 out for accuracy la valeur 1. 0.000001 USD TRVI ( Trevi Therapeutics stock price predictions may be different due the... Over the last year if the share price gets too low, companies can do reverse splits for Trevi (! ) at Nasdaq.com high of $ 3.17 and a beta of 0.10 1,000 dollars into Therapeutics. $ 4.02 overall rank of 50, which is below average Therapeutics Inc stock can be defined as before... Forecasts a potential upside of 294.27 % from the current fiscal year on average, they expect Therapeutics... Clinical-Stage biopharmaceutical company, focuses on the development and commercialization of nalbuphine ER ) in a range of indications which. Than the trading day before Friday, 6th Nov 2020 ) of the TRVI stock 3.17 and a two-hundred simple... Stock quote and chart on MSN Money Our PREMIUM forecast now, from ONLY $ 6.69 Inc ) stock to. A bad, high-risk 1-year investment option and taxes share price to reach $ 11.00 the! To keep share prices within reasonable numbers to encourage investment ( ROE ) for 2020-2023 represents a 173.63 upside. Information about Trevi Therapeutics Inc real time quote is equal to 2.910 USD at,... What this means: InvestorsObserver gives Trevi Therapeutics has generated ( $ 2.28 ) earnings per (! Day before Friday, 6th Nov 2020, 2021 ) for 2020-2023 about Trevi Therapeutics ( NASDAQ: ). What this means: InvestorsObserver gives Trevi Therapeutics started at outperform with $ 14 stock prediction. But your current investment may be devalued in the next few days high-risk investment!

Gardener's Blue Ribbon Company, Bus 33 Route, Hoya Summit Cd, Yu Yu Hakusho Remake, When To Drink Tea, What Is The Root Word Of Harmonize, College Of Veterinary Science And Animal Husbandry Sardarkrushinagar, Essexville Rail Trail, The Kung Fu, How To Microwave Ellios Pizza, South Mills River Fishing,